Right: Aaron Finley, Director of Deloitte China Strategic Client Center, Left: Deloitte China Audit and Assurance Partner/South China Listing Business Partner, Center: Jia Xiaojia, CEO of Eieling Technology

On May 31, Deloitte, which enjoys a high reputation in the field of global professional services, held an offline exchange meeting with Eieling Technology, an innovative technology company in the field of chronic liver disease, in Guangzhou to discuss all-round cooperation in financial auditing, taxation, and law. This cooperation aims to help Eieling Technology’s global business develop steadily and achieve broader market expansion and business growth. The two parties conducted in-depth discussions on financial risk management, international tax planning, and global strategic cooperation. Through Deloitte’s professional services and global network resources, Eieling Technology will effectively optimize its global business structure, improve operational efficiency, and reduce business risks. The two parties will work together to provide global users with better quality and more efficient medical services.

Eieling Technology CEO Jia Xiaojia takes a group photo with heads of various departments of HSBC

As one of the founding members of the HSBC Group, the Hong Kong and Shanghai Banking Corporation Limited has been committed to providing funds for trade activities between Asia and Europe since its establishment in 1865. Today, this largest bank registered in Hong Kong is supporting the global business expansion of small and medium-sized enterprises with the advantages of its global network and innovative services. On June 17, HSBC held in-depth exchanges with Eieling Technology at its headquarters in Hong Kong to explore how to provide “all-age” financial support for innovative technology companies including Eieling. During this offline exchange, the two sides had an in-depth discussion on how to combine their respective advantages to jointly promote innovation in medical technology and financial services. HSBC said that they valued the advanced technology of Eieling Technology in the field of liver disease diagnosis and the market potential of its products. With the successful experience of serving local science and technology enterprises in Hong Kong in the past, they hope to accelerate the technological progress in this field through financial support, and also explore new paths for the innovation of their financial services.

GE HealthCare BD Director Tian Pu and BD Manager Peng Chaojun visited Eieling Technology

On June 25, GE Healthcare and Eieling Technology held an offline exchange meeting in Shanghai. They conducted in-depth communication on all-round global business cooperation, intending to explore the combination of GE Healthcare’s leading advantages in medical technology, diagnostic drugs, and digital solutions with Eieling Technology’s innovative expertise in liver disease diagnostic technology and intelligent solutions. The two parties will jointly promote the improvement of the accuracy and treatment efficiency of early screening and early diagnosis of chronic liver disease, optimize hospital operating efficiency, and improve clinical diagnosis effectiveness by providing innovative comprehensive liver disease solutions and services, providing more intelligent liver disease solutions for global users, and lead the future direction of intelligent medical services.

Right: Lu Xiaoliang, Executive President of Xunfei Healthcare.Left: Jia Xiaojia, CEO of Eieling Technology

Recently, in the context of continuous innovation in the field of medical technology, Lu Xiaoliang, Executive President of Xunfei Healthcare, and Jia Xiaojia, CEO of Eieling Technology, had an in-depth offline exchange at the Xunfei headquarters in Hefei on the full-process patient service solution for AI-enabled liver disease.

Since its establishment in 2016, Xunfei Healthcare has established a core technology architecture system covering voice recognition, image recognition, and natural language understanding based on Xunfei’s more than 20 years of international leading intelligent voice and artificial intelligence technology accumulation.

As an innovative breakthrough enterprise in medical technology, Eieling Technology focuses on combining cutting-edge technology with the diagnosis and treatment of chronic liver disease. The flagship product Liverscan®️ , uses patented technologies such as real-time image guidance to bring patients accurate and reliable medical ultrasound solutions for chronic liver disease.

The two parties discussed that by integrating Xunfei Healthcare’s artificial intelligence technology and medical big models with Eieling Technology’s liver disease diagnosis technology, they could provide local governments and primary medical institutions with more efficient and convenient solutions for the entire process of early screening of liver cancer, improve the early diagnosis rate of liver disease and optimize treatment plans, realize the intelligence and efficiency of medical services, jointly promote the implementation of more innovative medical solutions, and inject more AI power into the innovation and development of the medical industry.